TelyRx Holdings Inc. faced a significant drop in its stock price, raising concerns among investors.
In yesterday's trading session, TelyRx Holdings Inc. experienced a sharp decline, closing down 5.45% at CA$2.60. This downturn comes despite recent financial disclosures that showed a revenue increase but also highlighted ongoing losses.
Investor takeaway: Investors should closely monitor TelyRx's financial performance and market reactions, especially considering its recent revenue growth juxtaposed with persistent losses.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$73.12M
52W high
$4.25
52W low
$2.00
1W change
+0.00%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 130.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+130.8% Upside
Current Price
C$2.60
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
115.0%
Annualized
90-Day Vol
102.2%
Annualized
Trend (90d)
-31.1%
Annualized drift
90d Mean
C$2.33
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.51 | C$1.68 – C$3.73 |
| 60 trading days | C$2.41 | C$1.38 – C$4.23 |
| 90 trading days | C$2.33 | C$1.17 – C$4.63 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Bull case
TelyRx's revenue growth is encouraging. In Q1 2026, revenues rose to CA$19.4 million, up from CA$14.3 million in the previous quarter. This suggests that the company has potential for future profitability as it expands its market presence.
Bear case
However, the company's net loss increased to CA$4.7 million in Q1 2026, raising concerns about its long-term viability and ability to manage costs effectively. The increasing losses overshadow the revenue growth, making investors wary.
Recent Financial Performance
TelyRx reported a revenue increase to CA$19.4 million in Q1 2026, but the net loss of CA$4.7 million raises questions about its financial health. Despite the growth in revenue, the ongoing losses have cast a shadow over the company's prospects.
Advertisement
Market Reaction
The stock's 5.45% decline reflects investor concerns about TelyRx's ability to turn revenue growth into sustainable profitability. As the market digests the latest financial results, investors may need to reevaluate their positions and consider the implications of the company’s ongoing losses.
Looking Ahead
As TelyRx navigates its financial challenges, investors should keep a close watch on upcoming earnings reports and market reactions. The company’s ability to manage costs and improve profit margins will be crucial for restoring investor confidence and stabilizing its stock price.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
